• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr. Susan Urba Discusses Cost Concerns for Treatment of Chemotherapy-Induced Nausea

Article

In this segment, Dr. Susan Urba, University of Michigan, Comprehensive Cancer Center, talks about treatment guidelines and decisions relevant to chemotherapy-induced nausea and vomiting (CINV) in a managed care setting.

In addition, Dr. Urba warns of the consequences associated with the treatment of CINV when cost concerns impact best practices. Often, these consequences can include increased costs from uncontrolled symptoms and potential hospital admission due to dehydration.

Related Videos
Eleanor Perfetto, PhD
Paula Rodríguez-Otero, MD, PhD
Tom Kim, chief medical officer, Sound Long-Term Care Management
Jonathan Strober, MD
Steven Manobianco, MD
Xiaotong Li, PhD, MS, Memorial Sloan Kettering Cancer Center
© 2025 MJH Life Sciences
AJMC®
All rights reserved.